Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 1Carcinoma, Ovarian Epithelial 1

Interventions

Psychiatric Rehabilitation 5Early Intervention, Educational 5Therapeutics 4Methods 4Counseling 3Massage 2Gene Expression Profiling 2Fenretinide 2Dexamethasone 2Calcium Dobesilate 2Aprepitant 2Analgesia 2taxane 1motexafin lutetium 1liposomal doxorubicin 1dexamethasone acetate 1dexamethasone 21-phosphate 1Yoga 1Watchful Waiting 1Voriconazole 1Vitamin D 1Trastuzumab 1Touch 1Taxes 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sugars 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Serotonin Plasma Membrane Transport Proteins 1Seprafilm 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Ovarian Epithelial × Ovariectomy × Clear all
NCT00084370 2013-08-22

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

University of Alabama at Birmingham

Phase NA Withdrawn
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡